Kestra Medical Technologies (KMTS) Operating Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has reported Operating Expenses for 3 consecutive years, with $55.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses fell 1.47% year-over-year to $55.0 million in Q2 2026; TTM through Apr 2026 was $183.6 million, a 40.6% increase from a year earlier, with the FY2026 full-year figure at $183.6 million, up 40.6% from the prior year.
• Operating Expenses was $55.0 million for Q2 2026 at Kestra Medical Technologies, up from $47.7 million in the prior quarter.
• Over five years, Operating Expenses peaked at $55.8 million in Q2 2025 and troughed at $20.8 million in Q1 2024.
• A 3-year average of $35.7 million and a median of $32.4 million in 2025 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses surged 156.81% in 2025 and slipped 1.47% in 2026, its largest moves.
• Over 3 years, Operating Expenses stood at $25.0 million in 2024, then jumped by 72.97% to $43.2 million in 2025, then advanced by 27.44% to $55.0 million in 2026.
• The last three Operating Expenses figures came in at $55.0 million (Q2 2026), $47.7 million (Q1 2026), and $43.2 million (Q4 2025), per Business Quant data.